Showing 1591-1600 of 1870 results for "".
- Glauconix Biosciences Promotes Kimberly Southern to Chief Executive Officerhttps://modernod.com/news/glauconix-biosciences-promotes-kimberly-southern-to-chief-executive-officer/2477262/Glauconix Biosciences announced that its board of directors has appointed Kim Southern as Chief Executive Officer and a member of the Board of Directors effective immediately. Ms. Southern previously held the position of Chief Operating Officer. Since joining the company in May, Ms. Southe
- EyePrint Prosthetics Announces Clinical Outcomes Achieved With EyePrintPROhttps://modernod.com/news/eyeprint-prosthetics-announces-clinical-outcomes-achieved-with-eyeprintpro/2480203/EyePrint Prosthetics, a company dedicated to restoring vision to patients who have complex corneal irregularities, announced the clinical outcomes that have been achieved since the EyePrintPRO lens was FDA-cleared 2 y
- CooperVision Completes National Campaign on Childhood Myopiahttps://modernod.com/news/coopervision-completes-national-campaign-on-childhood-myopia/2487078/Key Takeaways CooperVision launched a nationwide media campaign focused on raising awareness about childhood myopia and promoting early diagnosis, intervention, and proactive treatment. The campaign was led by Damaris Raymondi, OD, and Coralys Vega, MD, who
- Three Optometric Practices in Florida Partner With US Eyehttps://modernod.com/news/us-eye-expands-into-now-5-states-50-clinics-and-5-ascs-100-providers-and-1000-team-members/2480526/Three optometric practices in Florida have partnered with US Eye. The new partnerships include Rick Billings, OD; Hart Eye Care; and Precision Eye Care of Central Florida.
- Staar Surgical Announces Restructure of Leadershiphttps://modernod.com/news/staar-surgical-announces-restructure-of-leadership/2482705/Staar Surgical announced a series of changes to their leadership structure. These changes come in an effort to better address marketing needs, according to Staar. Warren Foust, Chief Operating Officer, has been promoted to the newly created role of Preside
- EyeCare Partners Names New Members to Executive Leadership Teamhttps://modernod.com/news/eyecare-partners-names-new-members-to-executive-leadership-team/2482321/EyeCare Partners announced new additions and changes to its executive leadership team. Appointments and changes are: Andrew Hardesty has been promoted to the new role of Chief Program Officer, effective immediately. This role oversees and lea
- Age-Related DNA Modifications Linked to Eye Disease Susceptibilityhttps://modernod.com/news/age-related-dna-modifications-linked-to-eye-disease-susceptibility/2477700/National Eye Institute (NEI) researchers profiling epigenomic changes in light-sensing mouse photoreceptors have a clearer picture of how age-related eye diseases may be linked to age-related changes in the regulation of gene expression. The findings, published in
- Lineage Cell Therapeutics Launches New Corporate Brandhttps://modernod.com/news/lineage-cell-therapeutics-launches-new-corporate-brand/2479549/Lineage Cell Therapeutics, previously BioTime, announced the effective change of its corporate name and formal launch of its new corporate brand. In connection with the launch, the company’s NYSE American ticker symbol has changed to “LCTX” and will be effective at the open of t
- Optical and Ophthalmology Cloud Solutions Provider KIDE Systems Becomes Topcon Healthcare Solutions EMEAhttps://modernod.com/news/optical-and-ophthalmology-cloud-solutions-provider-kide-systems-becomes-topcon-healthcare-solutions-emea/2476307/Following Topcon Healthcare Solutions’ acquisition of KIDE Systems in April 2018, KIDE Systems announced that it will take on the branding of its parent company Topcon Healthcare Solutions, part of Topcon Corporation. The brand change includes the change of KIDE System’s corporate name to Topcon
- Bausch Health CEO: No Plans to Divest Bausch + Lombhttps://modernod.com/news/valeant-now-officially-bausch-health-companies-begins-trading-as-bhc/2480016/Valeant Pharmaceuticals International completed its name change to Bausch Health Companies. In an interview with Eyewire News to discuss the name change and direction of Bausch + Lomb, Bausch Health Chairman and CEO Joseph Papa said there are no plans to divest the eye care unit. “B